 Shares of iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDB – Get Free Report) dropped 0.4% during trading on Thursday . The stock traded as low as $33.28 and last traded at $33.30. Approximately 11,166 shares changed hands during mid-day trading, an increase of 7% from the average daily volume of 10,468 shares. The stock had previously closed at $33.45.
Shares of iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDB – Get Free Report) dropped 0.4% during trading on Thursday . The stock traded as low as $33.28 and last traded at $33.30. Approximately 11,166 shares changed hands during mid-day trading, an increase of 7% from the average daily volume of 10,468 shares. The stock had previously closed at $33.45.
iShares LifePath Target Date 2030 ETF Trading Down 0.4%
The company has a market cap of $40.63 million, a price-to-earnings ratio of 20.07 and a beta of 0.60. The company’s 50 day moving average price is $32.85 and its 200 day moving average price is $31.52.
iShares LifePath Target Date 2030 ETF Company Profile
The iShares LifePath Target Date 2030 ETF (ITDB) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches.
Featured Articles
- Five stocks we like better than iShares LifePath Target Date 2030 ETF
- How to Buy Cheap Stocks Step by Step
- Why Microsoft’s Post-Earnings Dip Is a Buy-the-Pause Moment
- How to Start Investing in Real Estate
- NVIDIA’s Billion-Dollar Bet Puts Nokia Back in the Growth Game
- How to Profit From Growth Investing
- Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Receive News & Ratings for iShares LifePath Target Date 2030 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2030 ETF and related companies with MarketBeat.com's FREE daily email newsletter.

 
						 
						 
						 
						